Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naïve Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial

OBJECTIVE: The 200 units/mL formulation of insulin degludec (IDeg 200 units/mL) contains equal units of insulin in half the volume compared with the 100 units/mL formulation. We compared the efficacy and safety of IDeg 200 units/mL once daily with 100 units/mL insulin glargine (IGlar) in insulin-naï...

Descripción completa

Detalles Bibliográficos
Autores principales: Gough, Stephen C.L., Bhargava, Anuj, Jain, Rajeev, Mersebach, Henriette, Rasmussen, Søren, Bergenstal, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747917/
https://www.ncbi.nlm.nih.gov/pubmed/23715753
http://dx.doi.org/10.2337/dc12-2329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747917/
https://www.ncbi.nlm.nih.gov/pubmed/23715753
http://dx.doi.org/10.2337/dc12-2329

Ejemplares similares